格隆汇8月15日丨新宇环保(00436.HK)公布，截至2025年6月30日止六个月，收益约为165,119,000港元， 同比减少0.6%。公司拥有人应占亏损约为10,619,000港元，比2024年同期约20,248,000港元减少47.6%。 公司拥有人应占每股基本亏损为0.35港仙，对比2024年同期则每股基本亏损为0.67港仙。 ...

Core Viewpoint - Xinyu Environmental (00436) reported a mid-year performance for 2025, indicating a slight decline in revenue and a significant reduction in loss compared to the previous year [1] Financial Performance - Revenue for the period was approximately HKD 165 million, representing a year-on-year decrease of 0.6% [1] - The loss attributable to the company's owners was approximately HKD 10.619 million, which is a 47.6% decrease year-on-year [1] - Basic loss per share was reported at HKD 0.35 cents [1]

智通财经APP讯，新宇环保(00436)公布2025年中期业绩，收益约为1.65亿港元，同比减少0.6%。 公司 拥有人应占亏损约为1061.9万港元，同比减少47.6%。每股基本亏损为0.35港仙。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任何 部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 New Universe Environmental Group Limited 新宇環保集團有限公 司 （在開曼群島註冊成立之有限公司） （股份代號：436） 截至二零二五年六月三十日止六個月之 中期業績公佈 財務摘要 1 • 截至二零二五年六月三十日止六個月，收益約為165,119,000港元，比二零 二四年同期約166,070,000港元減少0.6%。 • 截至二零二五年六月三十日止六個月，淨虧損約為13,509,000港元，比二零 二四年同期約23,706,000港元減少43.0%。 • 截至二零二五年六月三十日止六個月，本公司擁有人應佔虧損約為 10,619,000港元，比二零二四年同期約20,248,000港元減少47.6%。 • 於二零二五年六月三十日，本公司擁有人應佔股本約為862,783,000港元， 對比二零二四年十二月三十一日約869,053,000港元減少0.7%。 • 於二零二五 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 FF301 II. 已發行股份及/或庫存股份變動 致：香港交易及結算所有限公司 公司名稱: 新宇環保集團有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00436 | 說明 | 新宇環保 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 100,000,000,000 | HKD | | 0.01 | HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 100,000,000,000 | HKD | | 0 ...

Financial Performance - For the year ended December 31, 2024, the Group's revenue from continuing operations decreased by 13.9% to HK$349,416,000 compared to the previous year[16]. - The Group recorded a post-tax loss of HK$31,605,000, an improvement from a net loss of HK$35,767,000 in the previous year[16]. - Adjusted EBITDA in 2024 decreased by 11.7% to HK$72,783,000, down from HK$82,450,000 in 2023[16]. - The loss attributable to owners of the Company was HK$26,335,000, compared to a loss of HK$28,582,000 in 2023[19]. - Total revenue for 2024 decreased by 13.9% to HK$349,416,000 compared to HK$405,612,000 in 2023[77]. - Revenue from environmental treatment and disposal services for industrial and medical wastes fell by 17.8% to HK$224,254,000[77]. - Average gross profit margin decreased from 16.1% in 2023 to 15.7% in 2024, reflecting a decline of 2.5%[77]. - Net loss for the year improved by 11.6% to HK$31,605,000 from HK$35,767,000 in the previous year[77]. - Basic and diluted loss per share improved to HK$0.87 from HK$1.09, a reduction of 20.2%[77]. Assets and Liabilities - Equity attributable to owners of the Company as of December 31, 2024, was HK$869,053,000, down from HK$908,251,000 in 2023[19]. - Total assets as of December 31, 2024, were HK$1,247,615,000, a decrease from HK$1,301,424,000 in 2023[162]. - Non-current assets decreased to HK$893,426,000 in 2024 from HK$969,911,000 in 2023, reflecting a decline of 7.8%[162]. - Total liabilities decreased to HK$283,165,000 from HK$288,065,000 in 2023, representing a decline of 0.3%[163]. - Current liabilities amounted to HK$246,862,000, down from HK$249,980,000 in 2023, indicating a reduction of 1%[163]. - Net current assets improved to HK$107,327,000, compared to HK$81,533,000 in 2023, reflecting an increase of 31.6%[163]. Cash Flow and Capital Expenditure - Cash and cash equivalents of the Group as of December 31, 2024, increased to HK$220,823,000 from HK$186,365,000 in 2023[19]. - The Group's cash and bank balances as of December 31, 2024, totaled HK$220,823,000, an increase from HK$186,365,000 in 2023[105]. - For the year ended December 31, 2024, the Group's capital expenditure for environmental treatment and disposal services for industrial and medical wastes was approximately HK$2,986,000, a decrease of 78.9% from HK$14,152,000 in 2023[98]. - The capital expenditure for industrial sewage and sludge treatment services in the Eco-plating Specialised Zone increased to approximately HK$23,149,000, up 287.5% from HK$5,974,000 in 2023[98]. Operational Highlights - The Company collected approximately 167,964 metric tonnes of waste for treatment and disposal in 2024, significantly up from 96,686 metric tonnes in 2023[46]. - Segment revenue from environmental treatment and disposal services for industrial and medical wastes was approximately HK$224,254,000 in 2024, down from HK$272,671,000 in 2023[46]. - The centralized sewage treatment plant handled 315,038 metric tonnes of plating sewage in 2024, down from 330,615 metric tonnes in 2023, indicating a decline of 4.7%[61]. - The Group's four subsidiaries maintained a licensed annual incineration capacity of 135,400 metric tonnes of hazardous waste and 11,800 metric tonnes of regulated medical waste as of December 31, 2024[70]. Strategic Initiatives - The Company plans to explore business restructuring opportunities in 2025 to enhance operational efficiency and financial performance[22]. - The Company aims to adapt its business strategies in response to ongoing market challenges and uncertainties[21]. - The Group is committed to exploring opportunities for business restructuring and industrial upgrading to enhance the sustainability of its environmental operations[71]. - The Group will strengthen marketing functions and contractual relationships with clients to ensure stable operations amid market transitions[150]. Human Resources - The Group had 401 full-time employees as of December 31, 2024, a reduction of 16.8% from 482 in 2023[136]. - Staff costs for the year ended December 31, 2024, were HK$71,574,000, a decrease of 19.8% from HK$89,272,000 in 2023[136]. - Employee compensation and benefits are aligned with current market levels, including bonuses and medical insurance[140]. Risks and Challenges - The Group faces significant competition in the hazardous waste treatment market, necessitating continuous upgrades to facilities and staff development to maintain competitiveness[149]. - The Group is dependent on the renewal of hazardous waste operating permission licenses from the PRC Government, which poses a risk of temporary suspension or delays in renewal[146]. - The Group faces credit risk from underperforming accounts receivable due to distressed clients amid increased economic uncertainties, necessitating regular assessments of recoverability[158]. - The economic conditions in Mainland China may affect hazardous waste discharge quantities and treatment service pricing, impacting the Group's operations[156].

Financial Performance - Total revenue from continuing operations decreased to HKD 349,416,000 in 2024 from HKD 405,612,000 in 2023, representing a decline of approximately 13.8%[2] - Adjusted EBITDA for 2024 was HKD 72,783,000, down from HKD 82,450,000 in 2023, a decrease of about 11.7%[2] - The loss attributable to shareholders improved to HKD 26,335,000 in 2024 from HKD 33,118,000 in 2023, reflecting a reduction of approximately 20.7%[5] - Basic and diluted loss per share improved to HKD 0.87 in 2024 from HKD 1.09 in 2023[5] - The net loss for the year was HKD 31,605,000, an improvement of 11.6% compared to a loss of HKD 35,767,000 in 2023[66] Revenue Breakdown - Revenue from hazardous waste incineration and landfill services was HKD 224,254,000, down 17.7% from HKD 272,671,000 in the previous year[24] - Revenue from industrial wastewater treatment and related management services was HKD 95,865,000, a decrease of 4.1% compared to HKD 100,481,000 in 2023[24] - Revenue from industrial and medical waste treatment services decreased by 17.8% to HKD 224,254,000 from HKD 272,671,000[66] Assets and Liabilities - Total assets decreased to HKD 1,247,615,000 in 2024 from HKD 1,301,424,000 in 2023, a decline of approximately 4.1%[8] - Total liabilities decreased to HKD 283,165,000 in 2024 from HKD 288,065,000 in 2023, a reduction of about 1.3%[9] - The total reportable segment assets decreased to HKD 1,220,984,000 in 2024 from HKD 1,278,479,000 in 2023, reflecting a reduction of approximately 4.5%[30] Cash Flow and Equities - Cash and cash equivalents increased to HKD 220,823,000 in 2024 from HKD 186,365,000 in 2023, an increase of about 18.4%[2] - The group’s equity attributable to shareholders was approximately HKD 869,053,000, a decrease from HKD 908,251,000 in the previous year[83] Expenses and Costs - Total employee costs decreased to HKD 71,574,000 in 2024, down 19.8% from HKD 89,272,000 in 2023[35] - Sales costs for 2024 were HKD 294,585,000, a reduction of 13.4% compared to HKD 340,195,000 in 2023[35] - Administrative expenses decreased by 12.2% to HKD 43,699,000 from HKD 49,771,000, primarily due to a reduction in workforce[66] Impairment and Recovery - The company reported a net impairment reversal of accounts receivable amounting to HKD 5,009,000 in 2024, compared to a net impairment loss of HKD 15,672,000 in 2023[30] - The company experienced a significant reduction in impairment losses on receivables, which decreased by 68.0% to HKD 5,009,000 from HKD 15,672,000[66] Market Conditions and Risks - The company faces a decline in operating revenue due to intense competition and oversupply in the hazardous waste incineration market, prompting a temporary suspension of some loss-making business units[63] - Increased competition in the hazardous waste disposal market has led to a significant rise in bargaining power for intermediaries, affecting profitability[104] - The economic conditions in mainland China may influence the volume of hazardous waste generated and the pricing for specific waste management services[106] Future Outlook and Strategy - The company plans to focus on improving operational efficiency and exploring new market opportunities to enhance revenue growth in the upcoming year[71] - The company aims to enhance its marketing capabilities and strengthen contracts with existing clients to stabilize operations during market transitions[104] - The company remains optimistic about the future despite uncertainties and challenges, focusing on improving operational conditions and restoring profitability[64] Corporate Governance - The board has proposed a final dividend of HKD 0.0016 per share from retained earnings for the year ending December 31, 2024, subject to shareholder approval[140] - The audit committee, composed of three independent non-executive directors, has reviewed the consolidated financial statements for the year ending December 31, 2024[137] - The company has confirmed compliance with the corporate governance code, except for the separation of the roles of chairman and CEO, which is currently held by the same individual[133]

Group 1 - A total of 220 stocks were investigated by institutions in the past week, with YHLO being the most researched stock [1] - YHLO had 123 institutions participating in the research, including 39 fund companies, 32 securities companies, and 15 insurance companies [2] - For 2024, YHLO reported a revenue of 1.992 billion yuan, a decrease of 2.99% year-on-year, and a net profit attributable to shareholders of 302 million yuan, down 15.03% [2] - YHLO's non-recurring net profit attributable to shareholders was 288 million yuan, an increase of 31.16% year-on-year [2] - YHLO expressed confidence in its growth potential, driven by the large-scale promotion of its iTLA MAX domestic production line and the commercialization of its fully automated biochemical analyzer [2] Group 2 - ZSL Pharma plans to strengthen its market presence through core products like Wuling Capsules and Bailin Tablets, targeting broader coverage in lower-tier cities and community health centers [3] - ZSL Pharma aims to enhance its OTC market presence and improve brand awareness through various promotional activities [3] - ZSL Pharma is focusing on internet marketing and strengthening its sales team to improve market expansion capabilities [3] Group 3 - Guangshengtang's clinical project for its hepatitis B treatment has been included in an innovative drug clinical trial optimization project, indicating recognition from drug regulatory authorities [3] - The inclusion in the trial optimization project is expected to accelerate the drug approval process, benefiting hepatitis B patients [4] - Guangshengtang's hepatitis B plan features unique innovations, including an all-oral regimen and potential suppression of cccDNA [4] Group 4 - The A-share market saw a strong rise, with the Shanghai Composite Index increasing by 1.39%, surpassing the 3400-point mark [4] - The average increase for stocks under institutional research was 1.32%, with Shenghong Technology experiencing the largest gain of nearly 38% [4] - Shenghong Technology's projected net profit for Q1 2025 is between 780 million and 980 million yuan, reflecting significant year-on-year and quarter-on-quarter growth [4] - Shenghong Technology attributes its performance to its strategy of embracing AI and collaborating with leading international clients [4] Group 5 - Xingtum Control, Chaohongji, Buke Co., and Litong Technology all saw stock price increases exceeding 15% in the past week [5] - Xingtum Control is focused on aerospace measurement and control management, indicating a clear demand in specialized fields [5] - The company also sees significant potential in aerospace digital simulation for future industry development [5]

Financial Performance - Revenue from continuing operations for the six months ended June 30, 2024, decreased by 17.2% to approximately HK$166,070,000 compared to approximately HK$200,638,000 for the corresponding period in 2023[7]. - Net loss for the six months ended June 30, 2024, was approximately HK$23,706,000, a decrease of 36.4% compared to approximately HK$37,247,000 for the corresponding period in 2023[7]. - Loss attributable to the owners of the Company for the six months ended June 30, 2024, was approximately HK$20,248,000, decreased by 38.9% compared to approximately HK$33,165,000 for the corresponding period in 2023[7]. - For the six months ended June 30, 2024, total revenue decreased by 17.2% to HK$166,070,000 compared to HK$200,638,000 in the same period of 2023[29]. - The net loss for the same period was approximately HK$23,706,000, a reduction of 36.4% from HK$37,247,000 in 2023[9]. - The loss attributable to owners of the company was approximately HK$20,248,000, down 38.9% from HK$33,165,000 in the previous year[9]. - Adjusted EBITDA increased by 9.1% to HK$29,221,000 compared to HK$26,794,000 in the same period of 2023[29]. - The gross profit margin for the Group decreased, mainly attributed to the decline in unit handling price of hazardous waste treatment services[30]. - The total comprehensive loss for the period attributable to owners of the Company was HK$15,019,000, compared to HK$66,498,000 in the prior year, indicating a significant reduction of 77.6%[150]. Cash and Liquidity - Cash and cash equivalents of the Group at June 30, 2024, was approximately HK$212,302,000, an increase of 13.9% compared to approximately HK$186,365,000 at December 31, 2023[7]. - The Group's cash and bank balances totaled HK$212,302,000 as of June 30, 2024, an increase from HK$186,365,000 as of December 31, 2023[37]. - The net cash generated from operating activities was HK$31,886, compared to a net cash used of HK$6,734 in the same period of 2023[159]. - The company reported a net cash used in investing activities of HK$11,682 for the six months ended June 30, 2024, compared to HK$26,737 in the same period of 2023[159]. - The Group's current ratio as of June 30, 2024, was 1.34 times, slightly up from 1.33 times on December 31, 2023[41]. Debt and Borrowings - Bank borrowings of the Group at June 30, 2024, was approximately HK$53,700,000, an increase of 22.0% compared to approximately HK$44,000,000 at December 31, 2023[8]. - The total interest-bearing borrowings increased to HK$53,864,000 as of June 30, 2024, compared to HK$44,332,000 on December 31, 2023, resulting in a gearing ratio of 5.5%, up from 4.4%[41]. - The secured RMB bank borrowings were HK$21,480,000 as of June 30, 2024, down from HK$22,000,000 on December 31, 2023[44]. Operational Highlights - The total segment revenue from environmental treatment and disposal services for industrial and medical wastes was approximately HK$105,297,000, compared to HK$138,808,000 in 2023[10]. - The Group collected approximately 45,591 metric tonnes of hazardous waste, slightly down from 45,792 metric tonnes in the same period last year[11]. - The average utilization rate of the centralized sewage treatment plant was 86.2%, down from 91.8% in 2023, while the average treatment capacity utilization increased to 20.3% from 15.7%[21]. - The Group's long-term equity investments in three plastic materials dyeing entities reported pre-tax profit margins of 2.6%, 2.7%, and 5.9% for Suzhou New Huamei, Danyang New Huamei, and Qingdao Huamei, respectively, compared to lower margins in 2023[23]. - The Group's revenue from integrated treatment and disposal services for hazardous waste was approximately HK$239,160,000 for 96,485 metric tonnes of waste collected and disposed, compared to HK$325,479,000 for 96,274 metric tonnes in the previous period[31]. Dividends and Shareholder Returns - The Board resolved not to declare a dividend for the six months ended June 30, 2024[8]. - The Board does not recommend the payment of an interim dividend for the six months ended June 30, 2024, while a final dividend of HK$0.0016 per ordinary share, totaling approximately HK$4,857,000, has been recognized as a liability[76]. Corporate Governance - The Company has complied with all code provisions of the Corporate Governance Code throughout the six months ended June 30, 2024, except for code provision C.2.1 regarding the separation of roles of Chairman and CEO[87]. - The roles of Chairman and CEO are currently held by the same individual, Mr. XI Yu, which the Board believes is appropriate for facilitating business strategy execution[88]. - The Company has adopted the Model Code for Securities Transactions by Directors, confirming compliance with the required standards throughout the six months ended June 30, 2024[91]. Legal and Regulatory Matters - The asset preservation order related to ongoing legal proceedings will remain in effect until March 17, 2025, unless extended or lifted by the court[60]. - The Group has not encountered any material non-compliance with relevant laws and regulations during the six months ended June 30, 2024, that significantly impacts its business operations[135]. Future Outlook - The Group remains optimistic about future operations and aims to return to profitability while maintaining a strong focus on environmental protection and waste management[27]. - The Group plans to explore business restructuring and industrial upgrading opportunities to enhance the sustainability of its environmental operations[26]. - The Group plans to strengthen its business strategy for geographical market penetration and explore business restructuring to reduce dependency on specific markets[74].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任何 部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 New Universe Environmental Group Limited 新宇環保集團有限公 司 （在開曼群島註冊成立之有限公司） （股票代號：436） 截至二零二四年六月三十日止六個月之 中期業績公佈 | --- | --- | |-------|--------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | 財務摘要 | | • | 截 至二零二四年六 月三十 日止六個月，來自持續經營業務之 收 益 約 為 166,070,000 港元，比二零二三年同期約 200,638,000 港元減少 17.2% 。 | | • | 截至二零二四年六月三十日 ...